- Cardinal Health invites independent pharmacy owners to ‘discover new horizons’ at RBC 2013
- USPLabs agrees to recall and destroy dietary supplement following FDA actions
- Facing pharmacy trends for the remainder of the year
- FDA director of Division of Dietary Supplement Programs to provide a keynote address at CRN event
- FDA approves Plan B One-Step OTC switch
WASHINGTON — The Council for Responsible Nutrition on Wednesday announced that Daniel Fabricant, director of the Division of Dietary Supplement Programs at the Food and Drug Administration, will deliver the keynote address at The Conference: CRN’s Annual Symposium for the Dietary Supplement Industry on Oct. 20 in Rancho Palos Verdes, Calif.
Fabricant, who recently joined the FDA following stints at the Natural Products Association and ConsumerLab.com, will address the agency’s priorities for the dietary supplement industry, including the FDA’s perspective on the newly released and controversial draft guidance for New Dietary Ingredients.
At the agency, Fabricant is responsible for the full implementation of DSHEA through the interpretation and enforcement of dietary supplement requirements that ensure the safety and truthful labeling of dietary supplements support legislative compliance, enforcement and public affairs initiatives.
“The dietary supplement and nutrition products industries are facing new and serious challenges, as evidenced by publication of [the] FDA's draft NDI guidance and the recent introduction of S. 1310 by Senator Richard Durbin,” stated John Venardos, chairman of the conference and SVP worldwide regulatory, government and industry affairs for Herbalife. “We are appreciative that Dr. Fabricant will engage with our participants at this industry-wide conference, and his insights will set the stage for a lively, provocative and informative meeting.”
Online registration is available through CRN’s website.